Kirk Siderman-Wolter
Direktor/Vorstandsmitglied bei Assurednano Ltd.
Profil
Kirk Siderman-Wolter is currently a Director at Assurednano Ltd.
and KSW Consultancy Ltd.
He previously worked as Finance Director & Director at Centre for Process Innovation Ltd., Director-Finance & Director at Nuformix Technologies Ltd., CFO & Senior Independent Non-Executive Director at Nuformix Plc, and Director at CFTBE Services Ltd., Consortium For The Built Environment Ltd., Lawns Blackheath Management Ltd., Together Southwark, and PolyPhotonix Ltd.
Mr. Siderman-Wolter holds an MBA degree from London Business School.
Aktive Positionen von Kirk Siderman-Wolter
| Unternehmen | Position | Beginn |
|---|---|---|
| Assurednano Ltd. | Direktor/Vorstandsmitglied | - |
| KSW Consultancy Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kirk Siderman-Wolter
| Unternehmen | Position | Ende |
|---|---|---|
| NUFORMIX PLC | Finanzdirektor/CFO | 10.09.2019 |
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Finanzdirektor/CFO | 09.09.2019 |
Centre for Process Innovation Ltd.
 Centre for Process Innovation Ltd. Investment ManagersFinance Centre for Process Innovation Ltd (CPI) is a venture capital firm founded in 2019. The firm is headquartered in Redcar, United Kingdom. | Finanzdirektor/CFO | - |
PolyPhotonix Ltd.
 PolyPhotonix Ltd. Medical SpecialtiesHealth Technology PolyPhotonix Ltd. is a bio-photonic research and British development company that specializes in designing, developing, and manufacturing noninvasive photonic-based medical devices. The company is based in Sedgefield, UK. The company's focus is on light therapy treatments for macular eye disease. PolyPhotonix's most notable product is the Noctura 400 sleep mask, which is an innovative, noninvasive, and monitored home care treatment developed to prevent and treat diabetic retinopathy. The company was founded in 2008 by Richard Kirk, who has been the CEO since its inception. | Direktor/Vorstandsmitglied | - |
| Together Southwark | Direktor/Vorstandsmitglied | - |
Ausbildung von Kirk Siderman-Wolter
| London Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NUFORMIX PLC | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Centre for Process Innovation Ltd.
Centre for Process Innovation Ltd. Investment ManagersFinance Centre for Process Innovation Ltd (CPI) is a venture capital firm founded in 2019. The firm is headquartered in Redcar, United Kingdom. | Finance |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Assurednano Ltd. | |
| KSW Consultancy Ltd. | |
| CFTBE Services Ltd. | |
| Consortium For The Built Environment Ltd. | |
| Lawns Blackheath Management Ltd. | |
| Together Southwark | |
PolyPhotonix Ltd.
PolyPhotonix Ltd. Medical SpecialtiesHealth Technology PolyPhotonix Ltd. is a bio-photonic research and British development company that specializes in designing, developing, and manufacturing noninvasive photonic-based medical devices. The company is based in Sedgefield, UK. The company's focus is on light therapy treatments for macular eye disease. PolyPhotonix's most notable product is the Noctura 400 sleep mask, which is an innovative, noninvasive, and monitored home care treatment developed to prevent and treat diabetic retinopathy. The company was founded in 2008 by Richard Kirk, who has been the CEO since its inception. | Health Technology |
